Annual EPS
-$3419.13
+$32.35 K+90.44%
01 December 2023
Summary:
TransCode Therapeutics annual earnings per share is currently -$3419.13, with the most recent change of +$32.35 thousand (+90.44%) on 01 December 2023. During the last 3 years, it has risen by +$10.60 thousand (+75.62%). RNAZ annual EPS is now -243.24% below its all-time high of -$996.12, reached on 31 December 2019.RNAZ EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$5.28
+$19.14+78.38%
01 September 2024
Summary:
TransCode Therapeutics quarterly earnings per share is currently -$5.28, with the most recent change of +$19.14 (+78.38%) on 01 September 2024. Over the past year, it has increased by +$209.71 (+97.54%). RNAZ quarterly EPS is now -100.09% below its all-time high of $6116.79, reached on 30 June 2021.RNAZ Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$266.14
+$1593.24+85.69%
01 September 2024
Summary:
TransCode Therapeutics TTM earnings per share is currently -$266.14, with the most recent change of +$1593.24 (+85.69%) on 01 September 2024. Over the past year, it has increased by +$12.53 thousand (+97.92%). RNAZ TTM EPS is now -629.94% below its all-time high of -$36.46, reached on 01 March 2020.RNAZ TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +97.5% | +97.9% |
| 3 y3 years | +75.6% | +99.9% | +98.1% |
| 5 y5 years | -243.2% | - | - |
RNAZ EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +90.4% | at high | +100.0% | at high | +99.3% |
| 5 y | 5 years | -243.2% | +90.4% | -100.1% | +100.0% | -629.9% | +99.3% |
| alltime | all time | -243.2% | +90.4% | -100.1% | +100.0% | -629.9% | +99.3% |
TransCode Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.28(-78.4%) | -$266.14(-85.7%) |
| June 2024 | - | -$24.42(+13.8%) | -$1859.38(-61.1%) |
| Mar 2024 | - | -$21.45(-90.0%) | -$4774.46(-62.7%) |
| Dec 2023 | -$3419.13(-90.4%) | -$214.99(-86.6%) | -$12.79 K(-44.5%) |
| Sept 2023 | - | -$1598.52(-45.6%) | -$23.04 K(-23.7%) |
| June 2023 | - | -$2939.51(-63.4%) | -$30.17 K(-17.9%) |
| Mar 2023 | - | -$8041.63(-23.1%) | -$36.75 K(+2.7%) |
| Dec 2022 | -$35.77 K | -$10.46 K(+19.7%) | -$35.77 K(+15.2%) |
| Sept 2022 | - | -$8736.48(-8.2%) | -$31.05 K(+14.6%) |
| June 2022 | - | -$9513.71(+34.6%) | -$27.09 K(+136.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7067.35(+23.2%) | -$11.46 K(-19.9%) |
| Dec 2021 | -$14.02 K(+170.4%) | -$5736.19(+20.2%) | -$14.32 K(+38.3%) |
| Sept 2021 | - | -$4773.99(-178.0%) | -$10.35 K(+20.1%) |
| June 2021 | - | $6116.79(-161.6%) | -$8619.44(-42.6%) |
| Mar 2021 | - | -$9923.31(+459.6%) | -$15.02 K(+192.7%) |
| Dec 2020 | -$5185.60(+420.6%) | - | - |
| Dec 2020 | - | -$1773.30(-41.7%) | -$5130.78(+52.8%) |
| Sept 2020 | - | -$3039.61(+980.1%) | -$3357.48(+956.2%) |
| June 2020 | - | -$281.41(+671.8%) | -$317.87(+771.8%) |
| Mar 2020 | - | -$36.46 | -$36.46 |
| Dec 2019 | -$996.12 | - | - |
FAQ
- What is TransCode Therapeutics annual earnings per share?
- What is the all time high annual EPS for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly EPS year-on-year change?
- What is TransCode Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for TransCode Therapeutics?
- What is TransCode Therapeutics TTM EPS year-on-year change?
What is TransCode Therapeutics annual earnings per share?
The current annual EPS of RNAZ is -$3419.13
What is the all time high annual EPS for TransCode Therapeutics?
TransCode Therapeutics all-time high annual earnings per share is -$996.12
What is TransCode Therapeutics quarterly earnings per share?
The current quarterly EPS of RNAZ is -$5.28
What is the all time high quarterly EPS for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly earnings per share is $6116.79
What is TransCode Therapeutics quarterly EPS year-on-year change?
Over the past year, RNAZ quarterly earnings per share has changed by +$209.71 (+97.54%)
What is TransCode Therapeutics TTM earnings per share?
The current TTM EPS of RNAZ is -$266.14
What is the all time high TTM EPS for TransCode Therapeutics?
TransCode Therapeutics all-time high TTM earnings per share is -$36.46
What is TransCode Therapeutics TTM EPS year-on-year change?
Over the past year, RNAZ TTM earnings per share has changed by +$12.53 K (+97.92%)